Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSPRODUCTOS PARA LA TOS Y RESFRIADO
La categoría de productos para la tos y el resfriado ha alcanzado una facturación de 61,1M€ en octubre, siendo un 22,7% mayor respecto a las cifras de septiembre.
A nivel anual, la facturación entre noviembre 2022 y octubre 2023, ha sido de 746,9M€, lo que supone un crecimiento de un 15,2% frente a los datos registrados entre noviembre 2021 y octubre 2022.
VITAMINA C Y PREPARACIONES INMUNOESTIMULANTES
Durante el mes de octubre se ha registrado un aumento de ventas de los productos que se engloban en las categorías de vitamina C y preparaciones inmunoestimulantes.
El crecimiento respecto al mes anterior es de 10,2% gracias a una facturación total de 4,9M€, correspondiendo 2M€ a productos con vitamina C, y 3M€ a preparaciones inmunoestimulantes. A nivel anual, sin embargo, la evolución entre noviembre 2022 y octubre 2023 es menos favorable, habiendo decrecido un 0,8% respecto los datos registrados entre noviembre 2021 y octubre 2022, al registrar una facturación de 50,3M€ en el periodo actual mencionado.
PRODUCTOS PARA EL CUIDADO DE LABIOS
La categoría de cuidado de labios ha aumentado sus ventas en el mes de octubre un 33,3% respecto a septiembre, gracias a una facturación total de 2,7M€.
A nivel anual, el aumento ha sido de un 29,2% con respecto a las cifras declaradas entre noviembre 2021 y octubre 2022, registrando en una facturación de 36,2 M€ entre noviembre 2022 y octubre 2023.